The standard escalation on a plotter The Wegovy (weight management) protocol escalates as follows: 0.25 mg weekly for four weeks, then 0.5 mg for four weeks, then 1.0 mg for four weeks, then 1.7 mg for four weeks, and finally 2.4 mg as the maintenance dose
This combination of factors has made GLP-1 analogues among the fastest-adopted drugs in medical history
Qualification depends on both body mass index (BMI) and related health concerns
Nausea, the most commonly reported side effect, typically appears during the first week of treatment, though the timing can vary between individuals
Symptoms include severe upper abdominal pain, especially after eating, fever, and jaundice